Enhanced YAP expression leads to EGFR TKI resistance in lung adenocarcinomas View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-01-10

AUTHORS

Ting-Fang Lee, Yu-Chi Tseng, Phung Anh Nguyen, Yu-Chuan Li, Chao-Chi Ho, Cheng-Wen Wu

ABSTRACT

Epidermal growth factor receptor (EGFR) mutation is prevalently expressed in lung adenocarcinoma cases and acts as one of the major driving oncogenes. EGFR tyrosine kinase inhibitors (TKIs) have been used in patients with EGFR-mutant as an effective targeted therapy in lung adenocarcinoma, but drug resistance and tumor recurrence inevitably occurs. Recently, Yes-associate protein (YAP) has been reported to promote multiple cancer cell properties, such as promoting cell proliferation, epithelial-mesenchymal transition and drug resistance. This study investigated the roles of YAP in TKI-resistant lung adenocarcinoma. In TKI-sensitive cells, enhanced YAP expression leads to TKI resistant. Also, upregulated YAP expression and activation were detected in long-term TKI-induced resistant cells. With reduced YAP expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in nude mice and Moreover, combined EGFR TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database. These observations revealed the importance of YAP in promoting TKI-resistance and combined YAP inhibition can be a potential therapy delaying the occurrence of TKI-resistance in lung adenocarcinoma. More... »

PAGES

271

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41598-017-18527-z

DOI

http://dx.doi.org/10.1038/s41598-017-18527-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1100203126

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29321482


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma of Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Cycle Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Proliferation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Models, Animal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ErbB Receptors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nuclear Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transcription Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Xenograft Model Antitumor Assays", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan", 
          "id": "http://www.grid.ac/institutes/grid.260770.4", 
          "name": [
            "Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Ting-Fang", 
        "id": "sg:person.01131726777.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131726777.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan", 
          "id": "http://www.grid.ac/institutes/grid.260770.4", 
          "name": [
            "Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tseng", 
        "givenName": "Yu-Chi", 
        "id": "sg:person.07766760461.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07766760461.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Population & Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Ohio, USA", 
          "id": "http://www.grid.ac/institutes/grid.67105.35", 
          "name": [
            "College of medical Science and Technology, Taipei Medical University, Taipei, Taiwan", 
            "Department of Population & Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Ohio, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nguyen", 
        "givenName": "Phung Anh", 
        "id": "sg:person.01017423143.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017423143.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dermatology Department, Wan-Fang Hospital, Taipei, Taiwan", 
          "id": "http://www.grid.ac/institutes/grid.416930.9", 
          "name": [
            "College of medical Science and Technology, Taipei Medical University, Taipei, Taiwan", 
            "Dermatology Department, Wan-Fang Hospital, Taipei, Taiwan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Yu-Chuan", 
        "id": "sg:person.0772671762.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772671762.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University Medical College, Taipei, Taiwan", 
          "id": "http://www.grid.ac/institutes/grid.412094.a", 
          "name": [
            "Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University Medical College, Taipei, Taiwan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ho", 
        "givenName": "Chao-Chi", 
        "id": "sg:person.01332360267.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332360267.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan", 
          "id": "http://www.grid.ac/institutes/grid.482251.8", 
          "name": [
            "Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan", 
            "Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan", 
            "Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wu", 
        "givenName": "Cheng-Wen", 
        "id": "sg:person.015265115024.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015265115024.45"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nm.3854", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005299046", 
          "https://doi.org/10.1038/nm.3854"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng.3228", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000416392", 
          "https://doi.org/10.1038/ng.3228"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng.3218", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035632957", 
          "https://doi.org/10.1038/ng.3218"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature11156", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024120060", 
          "https://doi.org/10.1038/nature11156"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-01-10", 
    "datePublishedReg": "2018-01-10", 
    "description": "Epidermal growth factor receptor (EGFR) mutation is prevalently expressed in lung adenocarcinoma cases and acts as one of the major driving oncogenes. EGFR tyrosine kinase inhibitors (TKIs) have been used in patients with EGFR-mutant as an effective targeted therapy in lung adenocarcinoma, but drug resistance and tumor recurrence inevitably occurs. Recently, Yes-associate protein (YAP) has been reported to promote multiple cancer cell properties, such as promoting cell proliferation, epithelial-mesenchymal transition and drug resistance. This study investigated the roles of YAP in TKI-resistant lung adenocarcinoma. In TKI-sensitive cells, enhanced YAP expression leads to TKI resistant. Also, upregulated YAP expression and activation were detected in long-term TKI-induced resistant cells. With reduced YAP expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in nude mice and Moreover, combined EGFR TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database. These observations revealed the importance of YAP in promoting TKI-resistance and combined YAP inhibition can be a potential therapy delaying the occurrence of TKI-resistance in lung adenocarcinoma.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s41598-017-18527-z", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1045337", 
        "issn": [
          "2045-2322"
        ], 
        "name": "Scientific Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "keywords": [
      "tyrosine kinase inhibitors", 
      "EGFR tyrosine kinase inhibitors", 
      "lung adenocarcinoma", 
      "TKI resistance", 
      "YAP expression", 
      "Taiwan National Health Insurance Research Database", 
      "National Health Insurance Research Database", 
      "epidermal growth factor receptor (EGFR) mutations", 
      "Health Insurance Research Database", 
      "drug resistance", 
      "YAP inhibitor", 
      "TKI-sensitive cells", 
      "TKI-resistant cells", 
      "lung cancer patients", 
      "EGFR-TKI resistance", 
      "lung adenocarcinoma cases", 
      "role of YAP", 
      "epithelial-mesenchymal transition", 
      "xenograft tumor size", 
      "tumor size", 
      "tumor recurrence", 
      "cancer patients", 
      "driving oncogene", 
      "adenocarcinoma cases", 
      "potential therapy", 
      "Research Database", 
      "nude mice", 
      "cancer cell properties", 
      "receptor mutations", 
      "adenocarcinoma", 
      "resistant cells", 
      "YAP inhibition", 
      "kinase inhibitors", 
      "importance of YAP", 
      "cell proliferation", 
      "patients", 
      "therapy", 
      "EGFR mutants", 
      "inhibitors", 
      "cell properties", 
      "cells", 
      "expression", 
      "statins", 
      "recurrence", 
      "associate protein", 
      "mice", 
      "YAP", 
      "survival", 
      "shRNA", 
      "inhibition", 
      "resistance", 
      "proliferation", 
      "activation", 
      "oncogene", 
      "mutations", 
      "cases", 
      "protein", 
      "study", 
      "database", 
      "role", 
      "occurrence", 
      "importance", 
      "acts", 
      "observations", 
      "size", 
      "properties", 
      "transition", 
      "growth factor receptor (EGFR) mutation", 
      "factor receptor (EGFR) mutation", 
      "major driving oncogenes", 
      "multiple cancer cell properties", 
      "TKI-resistant lung adenocarcinoma", 
      "upregulated YAP expression", 
      "long-term TKI", 
      "reduced YAP expression", 
      "Insurance Research database"
    ], 
    "name": "Enhanced YAP expression leads to EGFR TKI resistance in lung adenocarcinomas", 
    "pagination": "271", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1100203126"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41598-017-18527-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29321482"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41598-017-18527-z", 
      "https://app.dimensions.ai/details/publication/pub.1100203126"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_767.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s41598-017-18527-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41598-017-18527-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41598-017-18527-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41598-017-18527-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41598-017-18527-z'


 

This table displays all metadata directly associated to this object as RDF triples.

290 TRIPLES      22 PREDICATES      127 URIs      115 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41598-017-18527-z schema:about N0c01b8c9534f452bb69ae63690c4d734
2 N1b678780868f4a3cad781a111a2e9692
3 N2506b9caff2944b586df1fece42ff033
4 N2961fb42d2ee4280ac5efa826876b777
5 N2a52c076689c44c185ff910193a4cb64
6 N30fb6ef105df47f2adf8526942ed4ccc
7 N351000d73b3f4f9188380136201b4ef6
8 N421e84d425a244c09a9682e5c2cf8d85
9 N49acbf9b01e745039cea9ab335330f33
10 N74074b3aa7154ac392513b76eed5d746
11 N76dce1f5948f417395ae83fb6d843d5e
12 N79c1cfb8f59d4a11817f8ad5fece5128
13 N8f1dcc42c3a8405a834f277c96ce3a2d
14 Na14d0525d4d7497ba8a55cf43b8e8710
15 Nae96edb6a95542fdb964c5c341a5808a
16 Nb0572ef39f0240e29faba57f59c4abfe
17 Nb2d6a8cf3d6d4b7ea1067f7135f62bb9
18 Nb407650970a64b75a51e207dbbe82365
19 Nd21c3c07e9ca4b3c95c25a904046268f
20 Nda96d93195d34084b9298eebaa007b84
21 Nf8e547839c084cbaa927b93debfaf832
22 anzsrc-for:11
23 anzsrc-for:1112
24 schema:author N4bef2cc2d900497aadc5f70028722f6f
25 schema:citation sg:pub.10.1038/nature11156
26 sg:pub.10.1038/ng.3218
27 sg:pub.10.1038/ng.3228
28 sg:pub.10.1038/nm.3854
29 schema:datePublished 2018-01-10
30 schema:datePublishedReg 2018-01-10
31 schema:description Epidermal growth factor receptor (EGFR) mutation is prevalently expressed in lung adenocarcinoma cases and acts as one of the major driving oncogenes. EGFR tyrosine kinase inhibitors (TKIs) have been used in patients with EGFR-mutant as an effective targeted therapy in lung adenocarcinoma, but drug resistance and tumor recurrence inevitably occurs. Recently, Yes-associate protein (YAP) has been reported to promote multiple cancer cell properties, such as promoting cell proliferation, epithelial-mesenchymal transition and drug resistance. This study investigated the roles of YAP in TKI-resistant lung adenocarcinoma. In TKI-sensitive cells, enhanced YAP expression leads to TKI resistant. Also, upregulated YAP expression and activation were detected in long-term TKI-induced resistant cells. With reduced YAP expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in nude mice and Moreover, combined EGFR TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database. These observations revealed the importance of YAP in promoting TKI-resistance and combined YAP inhibition can be a potential therapy delaying the occurrence of TKI-resistance in lung adenocarcinoma.
32 schema:genre article
33 schema:inLanguage en
34 schema:isAccessibleForFree true
35 schema:isPartOf N4b2e72af980c4107820383fc8d766623
36 N94a1f14934ab44b6a8ae9d199cfb8312
37 sg:journal.1045337
38 schema:keywords EGFR mutants
39 EGFR tyrosine kinase inhibitors
40 EGFR-TKI resistance
41 Health Insurance Research Database
42 Insurance Research database
43 National Health Insurance Research Database
44 Research Database
45 TKI resistance
46 TKI-resistant cells
47 TKI-resistant lung adenocarcinoma
48 TKI-sensitive cells
49 Taiwan National Health Insurance Research Database
50 YAP
51 YAP expression
52 YAP inhibition
53 YAP inhibitor
54 activation
55 acts
56 adenocarcinoma
57 adenocarcinoma cases
58 associate protein
59 cancer cell properties
60 cancer patients
61 cases
62 cell proliferation
63 cell properties
64 cells
65 database
66 driving oncogene
67 drug resistance
68 epidermal growth factor receptor (EGFR) mutations
69 epithelial-mesenchymal transition
70 expression
71 factor receptor (EGFR) mutation
72 growth factor receptor (EGFR) mutation
73 importance
74 importance of YAP
75 inhibition
76 inhibitors
77 kinase inhibitors
78 long-term TKI
79 lung adenocarcinoma
80 lung adenocarcinoma cases
81 lung cancer patients
82 major driving oncogenes
83 mice
84 multiple cancer cell properties
85 mutations
86 nude mice
87 observations
88 occurrence
89 oncogene
90 patients
91 potential therapy
92 proliferation
93 properties
94 protein
95 receptor mutations
96 recurrence
97 reduced YAP expression
98 resistance
99 resistant cells
100 role
101 role of YAP
102 shRNA
103 size
104 statins
105 study
106 survival
107 therapy
108 transition
109 tumor recurrence
110 tumor size
111 tyrosine kinase inhibitors
112 upregulated YAP expression
113 xenograft tumor size
114 schema:name Enhanced YAP expression leads to EGFR TKI resistance in lung adenocarcinomas
115 schema:pagination 271
116 schema:productId N331e97baf9b9444884432320f0d3eb55
117 Nea61c8c959a8488b88f8ecf1ddf3fb25
118 Nfc9b64c68bd14fa8a9f6f56465f4a028
119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100203126
120 https://doi.org/10.1038/s41598-017-18527-z
121 schema:sdDatePublished 2021-11-01T18:32
122 schema:sdLicense https://scigraph.springernature.com/explorer/license/
123 schema:sdPublisher Nd4bc5fe8952d41ce858a90b81f0d98db
124 schema:url https://doi.org/10.1038/s41598-017-18527-z
125 sgo:license sg:explorer/license/
126 sgo:sdDataset articles
127 rdf:type schema:ScholarlyArticle
128 N0c01b8c9534f452bb69ae63690c4d734 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Humans
130 rdf:type schema:DefinedTerm
131 N1b678780868f4a3cad781a111a2e9692 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Xenograft Model Antitumor Assays
133 rdf:type schema:DefinedTerm
134 N2506b9caff2944b586df1fece42ff033 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Cell Cycle Proteins
136 rdf:type schema:DefinedTerm
137 N2961fb42d2ee4280ac5efa826876b777 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Gene Expression Regulation, Neoplastic
139 rdf:type schema:DefinedTerm
140 N2a52c076689c44c185ff910193a4cb64 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name ErbB Receptors
142 rdf:type schema:DefinedTerm
143 N30fb6ef105df47f2adf8526942ed4ccc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Mice
145 rdf:type schema:DefinedTerm
146 N331e97baf9b9444884432320f0d3eb55 schema:name dimensions_id
147 schema:value pub.1100203126
148 rdf:type schema:PropertyValue
149 N351000d73b3f4f9188380136201b4ef6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Cell Proliferation
151 rdf:type schema:DefinedTerm
152 N421e84d425a244c09a9682e5c2cf8d85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Disease Models, Animal
154 rdf:type schema:DefinedTerm
155 N49acbf9b01e745039cea9ab335330f33 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Antineoplastic Agents
157 rdf:type schema:DefinedTerm
158 N4b2e72af980c4107820383fc8d766623 schema:volumeNumber 8
159 rdf:type schema:PublicationVolume
160 N4bef2cc2d900497aadc5f70028722f6f rdf:first sg:person.01131726777.55
161 rdf:rest Naaf9b284f6fb47228a762a2cac04c0a2
162 N74074b3aa7154ac392513b76eed5d746 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Cell Survival
164 rdf:type schema:DefinedTerm
165 N76dce1f5948f417395ae83fb6d843d5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Transcription Factors
167 rdf:type schema:DefinedTerm
168 N79c1cfb8f59d4a11817f8ad5fece5128 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Protein Kinase Inhibitors
170 rdf:type schema:DefinedTerm
171 N8f1dcc42c3a8405a834f277c96ce3a2d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Nuclear Proteins
173 rdf:type schema:DefinedTerm
174 N94a1f14934ab44b6a8ae9d199cfb8312 schema:issueNumber 1
175 rdf:type schema:PublicationIssue
176 Na14d0525d4d7497ba8a55cf43b8e8710 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Lung Neoplasms
178 rdf:type schema:DefinedTerm
179 Naaf9b284f6fb47228a762a2cac04c0a2 rdf:first sg:person.07766760461.02
180 rdf:rest Nca2a5de476a84910981e0ff2b666ba87
181 Nae96edb6a95542fdb964c5c341a5808a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Adenocarcinoma of Lung
183 rdf:type schema:DefinedTerm
184 Nb0572ef39f0240e29faba57f59c4abfe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Cell Line, Tumor
186 rdf:type schema:DefinedTerm
187 Nb0b4676b0dc84166bb1d7d11bafc0cde rdf:first sg:person.015265115024.45
188 rdf:rest rdf:nil
189 Nb2d6a8cf3d6d4b7ea1067f7135f62bb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Male
191 rdf:type schema:DefinedTerm
192 Nb407650970a64b75a51e207dbbe82365 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Animals
194 rdf:type schema:DefinedTerm
195 Nb7ce3f2450f64dfaa807d6aa7c8d3b04 rdf:first sg:person.01332360267.49
196 rdf:rest Nb0b4676b0dc84166bb1d7d11bafc0cde
197 Nca2a5de476a84910981e0ff2b666ba87 rdf:first sg:person.01017423143.67
198 rdf:rest Nd17f6f8c1706496c8798ad7b860c89d6
199 Nd17f6f8c1706496c8798ad7b860c89d6 rdf:first sg:person.0772671762.19
200 rdf:rest Nb7ce3f2450f64dfaa807d6aa7c8d3b04
201 Nd21c3c07e9ca4b3c95c25a904046268f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Drug Resistance, Neoplasm
203 rdf:type schema:DefinedTerm
204 Nd4bc5fe8952d41ce858a90b81f0d98db schema:name Springer Nature - SN SciGraph project
205 rdf:type schema:Organization
206 Nda96d93195d34084b9298eebaa007b84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
207 schema:name Adenocarcinoma
208 rdf:type schema:DefinedTerm
209 Nea61c8c959a8488b88f8ecf1ddf3fb25 schema:name pubmed_id
210 schema:value 29321482
211 rdf:type schema:PropertyValue
212 Nf8e547839c084cbaa927b93debfaf832 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
213 schema:name Prognosis
214 rdf:type schema:DefinedTerm
215 Nfc9b64c68bd14fa8a9f6f56465f4a028 schema:name doi
216 schema:value 10.1038/s41598-017-18527-z
217 rdf:type schema:PropertyValue
218 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
219 schema:name Medical and Health Sciences
220 rdf:type schema:DefinedTerm
221 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
222 schema:name Oncology and Carcinogenesis
223 rdf:type schema:DefinedTerm
224 sg:journal.1045337 schema:issn 2045-2322
225 schema:name Scientific Reports
226 schema:publisher Springer Nature
227 rdf:type schema:Periodical
228 sg:person.01017423143.67 schema:affiliation grid-institutes:grid.67105.35
229 schema:familyName Nguyen
230 schema:givenName Phung Anh
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017423143.67
232 rdf:type schema:Person
233 sg:person.01131726777.55 schema:affiliation grid-institutes:grid.260770.4
234 schema:familyName Lee
235 schema:givenName Ting-Fang
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131726777.55
237 rdf:type schema:Person
238 sg:person.01332360267.49 schema:affiliation grid-institutes:grid.412094.a
239 schema:familyName Ho
240 schema:givenName Chao-Chi
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332360267.49
242 rdf:type schema:Person
243 sg:person.015265115024.45 schema:affiliation grid-institutes:grid.482251.8
244 schema:familyName Wu
245 schema:givenName Cheng-Wen
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015265115024.45
247 rdf:type schema:Person
248 sg:person.0772671762.19 schema:affiliation grid-institutes:grid.416930.9
249 schema:familyName Li
250 schema:givenName Yu-Chuan
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772671762.19
252 rdf:type schema:Person
253 sg:person.07766760461.02 schema:affiliation grid-institutes:grid.260770.4
254 schema:familyName Tseng
255 schema:givenName Yu-Chi
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07766760461.02
257 rdf:type schema:Person
258 sg:pub.10.1038/nature11156 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024120060
259 https://doi.org/10.1038/nature11156
260 rdf:type schema:CreativeWork
261 sg:pub.10.1038/ng.3218 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035632957
262 https://doi.org/10.1038/ng.3218
263 rdf:type schema:CreativeWork
264 sg:pub.10.1038/ng.3228 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000416392
265 https://doi.org/10.1038/ng.3228
266 rdf:type schema:CreativeWork
267 sg:pub.10.1038/nm.3854 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005299046
268 https://doi.org/10.1038/nm.3854
269 rdf:type schema:CreativeWork
270 grid-institutes:grid.260770.4 schema:alternateName Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan
271 Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan
272 schema:name Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan
273 Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan
274 rdf:type schema:Organization
275 grid-institutes:grid.412094.a schema:alternateName Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University Medical College, Taipei, Taiwan
276 schema:name Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University Medical College, Taipei, Taiwan
277 rdf:type schema:Organization
278 grid-institutes:grid.416930.9 schema:alternateName Dermatology Department, Wan-Fang Hospital, Taipei, Taiwan
279 schema:name College of medical Science and Technology, Taipei Medical University, Taipei, Taiwan
280 Dermatology Department, Wan-Fang Hospital, Taipei, Taiwan
281 rdf:type schema:Organization
282 grid-institutes:grid.482251.8 schema:alternateName Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan
283 schema:name Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan
284 Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan
285 Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan
286 rdf:type schema:Organization
287 grid-institutes:grid.67105.35 schema:alternateName Department of Population & Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Ohio, USA
288 schema:name College of medical Science and Technology, Taipei Medical University, Taipei, Taiwan
289 Department of Population & Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Ohio, USA
290 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...